EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiota-targeted modulation of the gut–kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives

Wenjuan Zhang, Kexin Zhang, Wei Xu, Xiaodong Sun, Ying Xue

Biochemical and Biophysical Research Communications · 2026-02 · 800 · 153294

DOI: 10.1016/j.bbrc.2026.153294 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-02. Verfasst von Wenjuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shandong Provincial Key Medical and Health Laboratory of Endocrinology and Metabolic Diseases, Affiliated…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Gastrointestinal Microbiome, Kidney. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Tongji University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is increasingly recognized as a systemic disorder driven by immune-metabolic dysfunction, in which the gut microbiota plays a pivotal role. Dysbiosis of the intestinal microbiota disrupts epithelial barrier integrity, promotes endotoxemia, and triggers chronic low-grade inflammation, contributing to renal injury and fibrosis. Conversely, declining kidney function exacerbates gut microbial imbalance and uremic toxin accumulation, forming a bidirectional pathological loop. Beyond the classical gut-kidney axis, recent findings highlight the existence of a multi-organ signaling network-encompassing immune, metabolic, and hematopoietic pathways-that mediates cross-talk between the gut and kidneys. Microbial metabolites such as short-chain fatty acids, indoxyl sulfate, and bile acids act as endocrine-like regulators modulating renal inflammation, fibrosis, and metabolic stress. This review outlines the mechanistic underpinnings of gut-derived renal injury, including gut-immune-kidney, gut-metabolism-kidney, and gut-bone marrow-kidney axes. We also discuss emerging microbiota-targeted therapies, including probiotics, engineered bacteria, fecal microbiota transplantation, and AI-based personalized interventions. Together, these insights support a systems-level redefinition of DKD and underscore the therapeutic potential of restoring gut microbial homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesGastrointestinal MicrobiomeKidneyHumansAnimalsFecal Microbiota TransplantationDysbiosisProbiotics

Stichwörter der Autor:innen

Diabetic kidney diseaseGutKidneyMicrobiota

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shandong Provincial Key Medical and Health Laboratory of Endocrinology and Metabolic Diseases, Affiliated Hospital of Shandong Second Medical University, Weifang, China; Clini…
  • Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: 1400062@tongji.edu.cn.

Förderung

  • Taishan Scholar Project of Shandong Province
  • Tongji University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, W., Zhang, K., Xu, W., Sun, X., & Xue, Y. (2026). Microbiota-targeted modulation of the gut–kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives. Biochemical and Biophysical Research Communications, 800, 153294. https://doi.org/10.1016/j.bbrc.2026.153294

Vancouver

Zhang W, Zhang K, Xu W, Sun X, Xue Y. Microbiota-targeted modulation of the gut–kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives. Biochemical and Biophysical Research Communications. 2026;800:153294. doi:10.1016/j.bbrc.2026.153294

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenjuan and Zhang, Kexin and Xu, Wei and Sun, Xiaodong and Xue, Ying},
  title = {Microbiota-targeted modulation of the gut–kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {800},
  pages = {153294},
  doi = {10.1016/j.bbrc.2026.153294}
}
Kostenlos starten →